Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | AAPG | SNDX | ||
| Company | Sarepta Therapeutics | Ascentage Pharma Group Intl ADR | Syndax Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.67 | 23.12 | 24.50 | ||
| High | 21.67 | 23.14 | 24.71 | ||
| Low | 19.72 | 22.89 | 23.44 | ||
| Latest | 19.97 | 23.04 | 23.49 | ||
| Change | -1.71 | +1.74 | -1.21 | ||
| % Change | -7.89% | +8.19% | -4.90% | ||
| Volume | 4,609,400 | 3,700 | 1,234,600 | ||
| 20-Day Average Volume | 3,531,395 | 3,670 | 1,476,305 | ||
| Previous Close | 21.68 | 21.30 | 24.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.61 | 23.05 | 23.45 | ||
| 20-Day Raw Stochastic | 53.39% | 63.39% | 54.25% | ||
| 20-Day Relative Strength | 54.25 | 47.21 | 55.66 | ||
| Weighted Alpha | -30.72 | -21.80 | +88.08 | ||
| Today's Opinion | Hold | 100% Sell | 100% Buy | ||
| Previous Opinion | 8% Sell | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 88% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.65% since 03/20/26 | +4.54% since 03/19/26 | -3.05% since 03/20/26 | ||
| Low | 16.67 on 03/23/26 | 19.11 on 03/20/26 | 23.44 on 03/27/26 | ||
| High | 23.85 on 03/25/26 | 23.14 on 03/27/26 | 25.59 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +19.15% since 02/27/26 | -4.40% since 02/26/26 | +8.20% since 02/27/26 | ||
| Low | 15.52 on 03/06/26 | 19.11 on 03/20/26 | 21.00 on 03/06/26 | ||
| High | 23.85 on 03/25/26 | 25.00 on 03/16/26 | 25.59 on 03/25/26 | ||
| 3-Month | |||||
| %Chg | -9.72% since 12/26/25 | -16.76% since 12/26/25 | +10.28% since 12/26/25 | ||
| Low | 15.52 on 03/06/26 | 19.11 on 03/20/26 | 19.21 on 02/27/26 | ||
| High | 24.68 on 01/26/26 | 28.81 on 01/09/26 | 25.59 on 03/25/26 | ||
| 6-Month | |||||
| %Chg | +8.77% since 09/26/25 | -38.28% since 09/26/25 | +49.81% since 09/26/25 | ||
| Low | 15.08 on 11/04/25 | 19.11 on 03/20/26 | 12.99 on 10/27/25 | ||
| High | 25.32 on 10/08/25 | 40.47 on 10/02/25 | 25.59 on 03/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,096,650 | 2,150,347 | 2,071,841 | ||
| Shares Outstanding, K | 104,990 | 93,331 | 88,201 | ||
| Annual Sales | 2,198,240,000 | 134,350,000 | 172,350,000 | ||
| Annual Net Income | -713,410,000 | -55,540,000 | -285,420,000 | ||
| Last Quarter Sales | 442,930,000 | N/A | 68,480,000 | ||
| Last Quarter Net Income | -282,850,000 | N/A | -68,010,000 | ||
| 60-Month Beta | 0.42 | 0.78 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -3.58 on 02/25/26 | N/A | -0.78 on 02/26/26 | ||
| Latest Earnings Date | 05/05/26 | 03/25/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||